Federico Innocenti Selected Research

Federico Innocenti Research Topics

Disease

63	Neoplasms (Cancer) 12/2022 - 05/2002
29	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2004
14	Neutropenia 01/2022 - 05/2002
10	Hypertension (High Blood Pressure) 12/2022 - 01/2016
9	Pancreatic Neoplasms (Pancreatic Cancer) 07/2022 - 08/2010
8	Leukemia 01/2022 - 08/2010
5	Diarrhea 12/2022 - 11/2004
3	Proteinuria 01/2022 - 01/2016
3	Genetic Risk Score 01/2022 - 01/2019
3	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2015 - 11/2007
2	Colonic Neoplasms (Colon Cancer) 12/2022 - 01/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2022 - 06/2007
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2003
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 11/2016
2	Disease Progression 11/2020 - 12/2019
2	Lung Neoplasms (Lung Cancer) 08/2011 - 09/2009
1	Adenocarcinoma 07/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 07/2022
1	Brain Neoplasms (Brain Tumor) 07/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 07/2022
1	Essential Hypertension 01/2022
1	Fatigue 10/2021
1	Residual Neoplasm 12/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2020
1	Rectal Neoplasms (Rectal Cancer) 12/2020
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Lymphoma (Lymphomas) 01/2020
1	Hypertriglyceridemia 01/2020
1	Microsatellite Instability 10/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2019
1	Metabolic Diseases (Metabolic Disease) 12/2018
1	Weight Loss (Weight Reduction) 04/2018
1	Thyroid Neoplasms (Thyroid Cancer) 12/2016
1	Thyroid Diseases (Thyroid Disease) 12/2016
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2016
1	Vitamin D Deficiency 08/2014

Drug/Important Bio-Agent (IBA)

27	Irinotecan (Camptosar)FDA LinkGeneric 12/2022 - 05/2003
21	Bevacizumab (Avastin)FDA Link 01/2022 - 08/2010
12	Pharmaceutical PreparationsIBA 01/2022 - 05/2002
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2009
9	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2016
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 07/2015
7	Cetuximab (Erbitux)FDA Link 01/2022 - 01/2016
7	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 05/2009
6	Leucovorin (Folinic Acid)FDA Link 01/2020 - 05/2009
6	Gemcitabine FDA Link 01/2019 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2011
4	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 03/2003
4	Vitamin D FDA LinkGeneric 12/2019 - 08/2014
3	Sorafenib (BAY 43-9006)FDA Link 12/2022 - 01/2019
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 12/2006
3	Genetic Markers (Genetic Marker)IBA 01/2021 - 04/2013
3	LipidsIBA 01/2020 - 05/2011
3	hydroxide ionIBA 12/2019 - 08/2014
3	ErbB Receptors (EGF Receptor)IBA 09/2009 - 03/2003
2	Topoisomerase InhibitorsIBA 07/2022 - 04/2009
2	ORALIT (ORS)IBA 01/2022 - 04/2013
2	regorafenibIBA 01/2022 - 10/2020
2	BilirubinIBA 01/2022 - 04/2004
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2022
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022 - 01/2022
2	Angiopoietin-2IBA 01/2022 - 01/2022
2	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 11/2016
2	25-hydroxyvitamin DIBA 12/2019 - 08/2014
2	Angiogenesis InhibitorsIBA 01/2019 - 10/2018
2	LigandsIBA 11/2018 - 01/2014
2	Biological ProductsIBA 01/2017 - 09/2013
2	Hormones (Hormone)IBA 12/2016 - 01/2016
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2009 - 11/2007
2	Ketoconazole (Nizoral)FDA LinkGeneric 11/2007 - 11/2004
1	folfirinoxIBA 07/2022
1	Neurofibromin 1 (Neurofibromin)IBA 01/2022
1	NucleotidesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Glipizide (Glucotrol)FDA LinkGeneric 12/2021
1	AdiponectinIBA 01/2021
1	LuciferasesIBA 01/2021
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2021
1	Coffee FDA Link 11/2020
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Calcifediol (Calcidiol)FDA Link 07/2019
1	exemestane (Aromasin)FDA Link 01/2019
1	Adenosine Monophosphate (AMP)IBA 12/2018
1	Angiogenic ProteinsIBA 11/2018
1	Vascular Endothelial Growth Factor CIBA 11/2018
1	Adenosine (Adenocard)FDA LinkGeneric 10/2018
1	fibroblast growth factor 21IBA 04/2018
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2017
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 12/2016
1	Letrozole (Femara)FDA LinkGeneric 01/2016
1	Cytotoxins (Cytolysins)IBA 12/2015
1	KIR ReceptorsIBA 01/2014

Therapy/Procedure

27	Therapeutics 12/2022 - 08/2003
20	Drug Therapy (Chemotherapy) 01/2022 - 04/2010
2	Biological Therapy 12/2019 - 01/2017
1	Drug Tapering 10/2021